Weekly Versus Three-Weekly Cisplatin in Concurrent Chemoradiotherapy for Head and Neck Squamous Cancers: A Prospective Study

Journal Title: Indian Journal of Cancer Education and Research - Year 2017, Vol 5, Issue 1

Abstract

Concurrent chemoradiotherapy (CT-RT) is often used as definitive treatment for patients with locally advanced head-and-neck squamous cancers (HNSCC). Concurrent cisplatin administered 3- weekly (100 mg/m2 on days 1, 22 and 43 of RT) is the accepted standard-of-care, but causes significant toxicity. This has resulted in altered administration schedules, including weekly (40mg/m2 ) regimen, with conflicting reports on identifying optimal schedule. We compared acute toxicity and response rates between patients on CT-RT receiving weekly and 3-weekly cisplatin in this prospective study. 56 patients received either weekly (40 mg/m2 ; 36 patients) or 3-weekly (100 mg/m2 ; 20 patients) cisplatin concurrently with 3D-conformal radiotherapy (70 Gy/35#/7 weeks) based on physician or patient preference. Patients receiving weekly schedule were older (57.9 vs 50.3 years; p=0.03), but the groups were comparable in other variables including gender, primary site and stage. Acute toxicities (myelosuppression, mucositis, dysphagia, weight loss, etc.) were frequent but similar betweengroups, excepting a significantly lower nausea/vomiting in weekly schedule (grade II in 8.3% vs. 50%; p=0.03). Two patients, both on weekly chemotherapy, expired of aspiration pneumonia during treatment. Complete response rates at 12 weeks were similar between the cohorts (77.7% vs 85% CR, respectively; p= 0.61). At median follow-up of 12 months (range: 4-21.5 months), the estimated disease-free survival (DFS) was comparable between regimens (72% and 78% at 15 months, respectively; p= 0.550). We conclude thatweekly-cisplatin is associated with lower incidence of nausea/vomiting, but has otherwise comparable acute toxicity profile to 3-weekly schedule. Response to treatment and DFS are similar between the two.

Authors and Affiliations

Najah Mohamed Nizam

Keywords

Related Articles

Clinical Profile and Outcomes of Acute Myeloid Leukemia: An Institutional Experience from South India

Background: Acute myeloid leukemia is a heterogenous clonal disorder of hematopoietic progenitor cells with different molecular genetic abnormalities, clinical characteristics and variable outcomes with currently availab...

Daily Online Cone Beam Computed Tomography (CBCT) to Assess Interfractional Motion in Patients with Intact Cervical Carcinoma Treated with Volumetric Modulated ARC Therapy (VMAT)

Aim: To analyse and correct inter­fractional set up error in cervical carcinoma patients with intact cervix, treated with VMAT technique through daily online kilo voltage cone beam CT. Materials and Methods: The presen...

Study of Automated Urine Analyser Iris IQ 200 in Predicting Urine Cultures

Background: Many automated urine analysers like IRIS IQ 200 and IChem Velocity (Beckman coulter) performing automated biochemical and microscopic examination are now available to improve the accuracy and productivity of...

Knowledge of Cervical Cancer and Its Screening among Female Healthcare Workers in Oshimili South Local Government Area of Delta State, Nigeria

Background: Cervical cancer is the second most common cancer among women worldwide. Despite strong evidence that cancer screening saves lives through early detection and treatment, there is lack of empirical studies on i...

Study on Bacterial Profile of Urinary Tract Infection and Antimicrobial Susceptibility Pattern among Pregnant Women: A Study from a Tertiary Care Hospital

Introduction: Urinary tract infections (UTI) are the most common infections in clinical practice. They can have serious complications on maternal and fetal outcome when they occur in pregnancy. Screening all pregnant wom...

Download PDF file
  • EP ID EP459770
  • DOI 10.21088/ijcer.2321.9815.5117.2
  • Views 84
  • Downloads 0

How To Cite

Najah Mohamed Nizam (2017). Weekly Versus Three-Weekly Cisplatin in Concurrent Chemoradiotherapy for Head and Neck Squamous Cancers: A Prospective Study. Indian Journal of Cancer Education and Research, 5(1), 9-12. https://europub.co.uk/articles/-A-459770